Ronnie Moas Downgrades Kite Pharma, Sees $100 Stock Price Through 2018
November 14, 2015 at 14:49 PM EST
In a recent report, Standpoint Research Founder Ronnie Moas downgraded his rating on shares of Kite Pharma Inc (NASDAQ: KITE) from Buy ...
